Senior insider sale
Chief Medical Officer at DENALI THERAPEUTICS INC. — senior position signals high conviction
$35.8K
1.88K shares
What this filing means
HO CAROLE plans to sell 1.88K shares of DENALI THERAPEUTICS INC. valued at approximately $35.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/4/2025ACC: 0001950047-25-009799
Officer· Chief Medical Officer
Since Aug 2018
1.88K
Shares to sell
$35.8K
Approx. market value
1.88K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
8/9/2025
1.88KTotal acquired1.88K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/9/2025 | Restricted Stock Units N/A | 1.88K | — |
| Total | 1.88K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.88K
Market value
$35.8K
12/4/2025
Total
Units
1.88K
Value
$35.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/4/2025 | 1.88K | $35.8K | NASDAQ | Planned |
| Total | 1.88K | $35.8K | ||